PRECIOUS

PRECIOUS will revolutionise cancer treatment

PRECIOUS will revolutionise cancer treatment

The PRECIOUS (scaling-up immunomodulating nanomedicines for multimodal precision cancer immunotherapy) project will establish a platform for the development of new medicines that contain immunomodulating components acting at multiple levels.  ‘These novel medicines will act as a ‘two-sided knife’ by boosting the immune system, and at the same time attacking the immunosuppressive microenvironment that characterises theRead more about PRECIOUS will revolutionise cancer treatment[…]

€8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer

€8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer

An international multi-disciplinary consortium of 11 partners, in which 5 leading academic institutes, 4 cutting-edge biotech companies and 2 excellent service providers will join forces to advance the treatment of cancer using an innovative immunotherapeutic nanomedicin, has received an €8.3 million Horizon 2020 grant (grant agreement No 686089). The PRECIOUS consortium will be coordinated byRead more about €8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer[…]